195 related articles for article (PubMed ID: 29170515)
1. Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma.
Sonohara F; Inokawa Y; Hayashi M; Yamada S; Sugimoto H; Fujii T; Kodera Y; Nomoto S
Sci Rep; 2017 Nov; 7(1):16142. PubMed ID: 29170515
[TBL] [Abstract][Full Text] [Related]
2. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
3. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
5. [Long non-coding RNA HULC affects downstream-related targets to regulate migration and invasion of hepatoma cells].
Zhou C; Wu H; Liu Y; Yin C; Yang B
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):513-518. PubMed ID: 30317774
[No Abstract] [Full Text] [Related]
6. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.
Wu M; Lin Z; Li X; Xin X; An J; Zheng Q; Yang Y; Lu D
Sci Rep; 2016 Oct; 6():36045. PubMed ID: 27782152
[TBL] [Abstract][Full Text] [Related]
7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
8. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.
Yang Z; Lu Y; Xu Q; Tang B; Park CK; Chen X
Dis Markers; 2015; 2015():191029. PubMed ID: 26136615
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
Chen L; Yao H; Wang K; Liu X
J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
[TBL] [Abstract][Full Text] [Related]
10. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
[TBL] [Abstract][Full Text] [Related]
11. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
Xie H; Ma H; Zhou D
Biomed Res Int; 2013; 2013():136106. PubMed ID: 23762823
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
13. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.
Li J; Wang X; Tang J; Jiang R; Zhang W; Ji J; Sun B
Cell Physiol Biochem; 2015; 37(2):687-96. PubMed ID: 26356260
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
15. lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein.
Xiong H; Li B; He J; Zeng Y; Zhang Y; He F
Biochem Biophys Res Commun; 2017 Aug; 490(3):693-699. PubMed ID: 28634076
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HULC regulates the NF-κB pathway and represents a promising prognostic biomarker in liver cancer.
Liu S; Huttad L; He G; He W; Liu C; Cai D; Chen H; Qiu J
Cancer Med; 2023 Feb; 12(4):5124-5136. PubMed ID: 36213936
[TBL] [Abstract][Full Text] [Related]
17. Highly upregulated in liver cancer (HULC): An update on its role in carcinogenesis.
Ghafouri-Fard S; Esmaeili M; Taheri M; Samsami M
J Cell Physiol; 2020 Dec; 235(12):9071-9079. PubMed ID: 32372477
[TBL] [Abstract][Full Text] [Related]
18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
19. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
Zhang T; Cao C; Wu D; Liu L
Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
